- Home
- CODA vs STRO Comparison
CODA vs STRO Comparison
Compare CODA & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- STRO
- Stock Information
- Founded
- CODA 1994
- STRO 2003
- Country
- CODA United States
- STRO United States
- Employees
- CODA N/A
- STRO N/A
- Industry
- CODA Industrial Machinery/Components
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CODA Industrials
- STRO Health Care
- Exchange
- CODA Nasdaq
- STRO Nasdaq
- Market Cap
- CODA 85.8M
- STRO 77.7M
- IPO Year
- CODA N/A
- STRO 2018
- Fundamental
- Price
- CODA $7.93
- STRO $0.88
- Analyst Decision
- CODA Strong Buy
- STRO Hold
- Analyst Count
- CODA 1
- STRO 7
- Target Price
- CODA $11.00
- STRO $3.97
- AVG Volume (30 Days)
- CODA 58.5K
- STRO 513.9K
- Earning Date
- CODA 09-15-2025
- STRO 08-12-2025
- Dividend Yield
- CODA N/A
- STRO N/A
- EPS Growth
- CODA 21.86
- STRO N/A
- EPS
- CODA 0.30
- STRO N/A
- Revenue
- CODA $22,758,966.00
- STRO $66,434,000.00
- Revenue This Year
- CODA $30.82
- STRO N/A
- Revenue Next Year
- CODA $20.84
- STRO N/A
- P/E Ratio
- CODA $25.09
- STRO N/A
- Revenue Growth
- CODA 24.78
- STRO N/A
- 52 Week Low
- CODA $5.76
- STRO $0.52
- 52 Week High
- CODA $9.89
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- CODA 51.98
- STRO 57.66
- Support Level
- CODA $7.50
- STRO $0.83
- Resistance Level
- CODA $8.01
- STRO $1.01
- Average True Range (ATR)
- CODA 0.47
- STRO 0.07
- MACD
- CODA -0.08
- STRO 0.01
- Stochastic Oscillator
- CODA 50.18
- STRO 51.67
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.